A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?

Kidney Int. 2021 Oct;100(4):937-938. doi: 10.1016/j.kint.2021.07.026. Epub 2021 Aug 17.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / chemically induced
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
  • COVID-19 Vaccines
  • COVID-19*
  • ChAdOx1 nCoV-19
  • Humans
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19